Latest debt-to-equity ratio
Rapport Therapeutics Debt-to-equity ratio
Direct answer
Rapport Therapeutics's debt-to-equity ratio is 2.39%.
The verified market snapshot reports 2.39%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 3, 2026.
Get free Rapport Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.39%
Explore related company data
View Rapport Therapeutics's market capitalizationView Rapport Therapeutics's price-to-book ratioView Rapport Therapeutics's return on equityView Rapport Therapeutics's 52-week price rangeView Rapport Therapeutics's profit marginView all Rapport Therapeutics key metricsReturn to Rapport Therapeutics profile